PubMed:22797576
Annnotations
DisGeNET
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T0 | 410-414 | gene:596 | denotes | BCL2 |
| T1 | 472-475 | disease:C0005684 | denotes | BCa |
| T2 | 410-414 | gene:596 | denotes | BCL2 |
| T3 | 472-475 | disease:C0699885 | denotes | BCa |
| T4 | 410-414 | gene:596 | denotes | BCL2 |
| T5 | 560-563 | disease:C0005684 | denotes | BCa |
| T6 | 410-414 | gene:596 | denotes | BCL2 |
| T7 | 560-563 | disease:C0699885 | denotes | BCa |
| T8 | 424-428 | gene:331 | denotes | XIAP |
| T9 | 472-475 | disease:C0005684 | denotes | BCa |
| T10 | 424-428 | gene:331 | denotes | XIAP |
| T11 | 472-475 | disease:C0699885 | denotes | BCa |
| T12 | 424-428 | gene:331 | denotes | XIAP |
| T13 | 560-563 | disease:C0005684 | denotes | BCa |
| T14 | 424-428 | gene:331 | denotes | XIAP |
| T15 | 560-563 | disease:C0699885 | denotes | BCa |
| R1 | T0 | T1 | associated_with | BCL2,BCa |
| R2 | T2 | T3 | associated_with | BCL2,BCa |
| R3 | T4 | T5 | associated_with | BCL2,BCa |
| R4 | T6 | T7 | associated_with | BCL2,BCa |
| R5 | T8 | T9 | associated_with | XIAP,BCa |
| R6 | T10 | T11 | associated_with | XIAP,BCa |
| R7 | T12 | T13 | associated_with | XIAP,BCa |
| R8 | T14 | T15 | associated_with | XIAP,BCa |
PubmedHPO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 112-126 | HP_0009725 | denotes | Bladder cancer |
| T2 | 120-126 | HP_0002664 | denotes | cancer |
| T3 | 366-372 | HP_0002664 | denotes | cancer |
| T4 | 1406-1420 | HP_0009725 | denotes | bladder cancer |
| T5 | 1414-1420 | HP_0002664 | denotes | cancer |
Allie
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| SS1_22797576_1_0 | 112-126 | expanded | denotes | Bladder cancer |
| SS2_22797576_1_0 | 128-131 | abbr | denotes | BCa |
| AE1_22797576_1_0 | SS1_22797576_1_0 | SS2_22797576_1_0 | abbreviatedTo | Bladder cancer,BCa |
DisGeNET5_gene_disease
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| 22797576-0#69#73#gene331 | 69-73 | gene331 | denotes | XIAP |
| 22797576-0#90#104#diseaseC0005684 | 90-104 | diseaseC0005684 | denotes | bladder cancer |
| 22797576-0#90#104#diseaseC0005695 | 90-104 | diseaseC0005695 | denotes | bladder cancer |
| 22797576-0#90#104#diseaseC0699885 | 90-104 | diseaseC0699885 | denotes | bladder cancer |
| 22797576-9#51#55#gene596 | 1327-1331 | gene596 | denotes | BCL2 |
| 22797576-9#130#144#diseaseC0005684 | 1406-1420 | diseaseC0005684 | denotes | bladder cancer |
| 22797576-9#130#144#diseaseC0005695 | 1406-1420 | diseaseC0005695 | denotes | bladder cancer |
| 22797576-9#130#144#diseaseC0699885 | 1406-1420 | diseaseC0699885 | denotes | bladder cancer |
| 69#73#gene33190#104#diseaseC0005684 | 22797576-0#69#73#gene331 | 22797576-0#90#104#diseaseC0005684 | associated_with | XIAP,bladder cancer |
| 69#73#gene33190#104#diseaseC0005695 | 22797576-0#69#73#gene331 | 22797576-0#90#104#diseaseC0005695 | associated_with | XIAP,bladder cancer |
| 69#73#gene33190#104#diseaseC0699885 | 22797576-0#69#73#gene331 | 22797576-0#90#104#diseaseC0699885 | associated_with | XIAP,bladder cancer |
| 51#55#gene596130#144#diseaseC0005684 | 22797576-9#51#55#gene596 | 22797576-9#130#144#diseaseC0005684 | associated_with | BCL2,bladder cancer |
| 51#55#gene596130#144#diseaseC0005695 | 22797576-9#51#55#gene596 | 22797576-9#130#144#diseaseC0005695 | associated_with | BCL2,bladder cancer |
| 51#55#gene596130#144#diseaseC0699885 | 22797576-9#51#55#gene596 | 22797576-9#130#144#diseaseC0699885 | associated_with | BCL2,bladder cancer |
DisGeNet-2017-sample
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1326 | 69-73 | gene:331 | denotes | XIAP |
| T1327 | 90-104 | disease:C0005684 | denotes | bladder cancer |
| T1328 | 1327-1331 | gene:596 | denotes | BCL2 |
| T1329 | 1406-1420 | disease:C0005684 | denotes | bladder cancer |
| R1 | T1326 | T1327 | associated_with | XIAP,bladder cancer |
| R2 | T1326 | T1327 | associated_with | XIAP,bladder cancer |
| R3 | T1326 | T1327 | associated_with | XIAP,bladder cancer |
| R4 | T1328 | T1329 | associated_with | BCL2,bladder cancer |
| R5 | T1328 | T1329 | associated_with | BCL2,bladder cancer |
| R6 | T1328 | T1329 | associated_with | BCL2,bladder cancer |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| TextSentencer_T1 | 0-111 | Sentence | denotes | Simultaneous siRNA-mediated knockdown of antiapoptotic BCL2, Bcl-xL, XIAP and survivin in bladder cancer cells. |
| TextSentencer_T2 | 112-187 | Sentence | denotes | Bladder cancer (BCa) represents the ninth most common malignancy worldwide. |
| TextSentencer_T3 | 188-317 | Sentence | denotes | Despite intensive treatment with surgery and chemotherapy the prognosis for BCa patients particularly at advanced stages is poor. |
| TextSentencer_T4 | 318-379 | Sentence | denotes | The ability to evade apoptosis is a hallmark of cancer cells. |
| TextSentencer_T5 | 380-612 | Sentence | denotes | Since the antiapoptotic genes BCL2, Bcl-xL, XIAP and survivin are frequently upregulated in BCa tissues, their combined siRNA-mediated knockdown might be more potent in decreasing BCa growth than the single inhibition of one target. |
| TextSentencer_T6 | 613-766 | Sentence | denotes | Against each target two siRNAs were selected that specifically reduced the mRNA and protein levels of their appropriate target in EJ28 and J82 BCa cells. |
| TextSentencer_T7 | 767-912 | Sentence | denotes | Inhibition of survivin provoked the strongest antiproliferative effect of all single target treatments, for example cell counts decreased by 50%. |
| TextSentencer_T8 | 913-1119 | Sentence | denotes | Simultaneous targeting of all four antiapoptotic genes downregulated expression levels of all targets and mediated significant reductions in cell viability and cell counts as well as induction of apoptosis. |
| TextSentencer_T9 | 1120-1275 | Sentence | denotes | In EJ28 cells, combined knockdown of BCL2, Bcl-xL, XIAP and survivin caused a 2.5-fold enhancement in apoptosis rate and reduced cellular viability by 40%. |
| TextSentencer_T10 | 1276-1421 | Sentence | denotes | Therefore, simultaneous knockdown of antiapoptotic BCL2, Bcl‑xL, XIAP and survivin may represent a promising treatment option for bladder cancer. |
| T1 | 0-111 | Sentence | denotes | Simultaneous siRNA-mediated knockdown of antiapoptotic BCL2, Bcl-xL, XIAP and survivin in bladder cancer cells. |
| T2 | 112-187 | Sentence | denotes | Bladder cancer (BCa) represents the ninth most common malignancy worldwide. |
| T3 | 188-317 | Sentence | denotes | Despite intensive treatment with surgery and chemotherapy the prognosis for BCa patients particularly at advanced stages is poor. |
| T4 | 318-379 | Sentence | denotes | The ability to evade apoptosis is a hallmark of cancer cells. |
| T5 | 380-612 | Sentence | denotes | Since the antiapoptotic genes BCL2, Bcl-xL, XIAP and survivin are frequently upregulated in BCa tissues, their combined siRNA-mediated knockdown might be more potent in decreasing BCa growth than the single inhibition of one target. |
| T6 | 613-766 | Sentence | denotes | Against each target two siRNAs were selected that specifically reduced the mRNA and protein levels of their appropriate target in EJ28 and J82 BCa cells. |
| T7 | 767-912 | Sentence | denotes | Inhibition of survivin provoked the strongest antiproliferative effect of all single target treatments, for example cell counts decreased by 50%. |
| T8 | 913-1119 | Sentence | denotes | Simultaneous targeting of all four antiapoptotic genes downregulated expression levels of all targets and mediated significant reductions in cell viability and cell counts as well as induction of apoptosis. |
| T9 | 1120-1275 | Sentence | denotes | In EJ28 cells, combined knockdown of BCL2, Bcl-xL, XIAP and survivin caused a 2.5-fold enhancement in apoptosis rate and reduced cellular viability by 40%. |
| T10 | 1276-1421 | Sentence | denotes | Therefore, simultaneous knockdown of antiapoptotic BCL2, Bcl‑xL, XIAP and survivin may represent a promising treatment option for bladder cancer. |
UBERON-AE
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-UBERON-AE-B_T1 | 476-483 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissues |
performance-test
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| PD-UBERON-AE-B_T1 | 476-483 | http://purl.obolibrary.org/obo/UBERON_0000479 | denotes | tissues |